dan pharmaceuticals ltd
Trade trend analysis
Number of Transactions Quantity Weight
Number of Transactions Quantity Weight
The above chart presents the market trend analysis for dan pharmaceuticals ltd from 2025 to 2026. By examining various dimensions such as transaction quantity, transaction weight, average price, and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability. As of 2026, the company has completed 2 transactions, with a transaction quantity of 35 and a transaction weight of 0.
- Year Transactions Quantity Weight
- 2025 0 0 0
- 2026 2 35 0
Bill of lading data
< 1/2 >- Trade date 2026/06/12 B/L No. kpae-sb-96809-12-06-2026
- Suppliers buraq corporate fze llc Buyers dan pharmaceuticals ltd
- POLs kpae PODs ——
- Supply area Pakistan Purchas area Cambodia
- Weight —— Amount 277415
- Hs code 30042000 Product tags l 50,metoprolol tartrate usp,mero
- Product description EP/004220/62026 DATE OF ISSUE 10-06-2026 MEROL 50MG METOPROLOL TARTRATE USP Expand
- Trade date 2026/05/24 B/L No. kpae-sb-92183-24-05-2026
- Suppliers buraq corp fze llc Buyers dan pharmaceuticals ltd
- POLs kpae PODs ——
- Supply area Pakistan Purchas area Cambodia
- Weight —— Amount 1028872
- Hs code 30042000 Product tags novo,flex,pen,insulin aspart
- Product description EP/003850/52026 DATE OF ISSUE 20-05-2026 NOVO MIX 30MG FLEX PEN 100U/ML INSULIN ASPART BIPHASIC Expand
Partners
Total 2- Rank Company Transactions Per Detail
- 1 buraq corp fze llc pakistanbuyer,they trade on 2026-05-24 1 50.00% >
- 2 buyer,they trade on 2026-06-12 1 50.00% >
Products
Total 4- Products Transactions Per Detail
-
flex
1 100% > -
insulin aspart
1 100% > -
novo
1 100% > -
pen
1 100% >
Hscode rank
Total 1- HSCode Name Transactions Per Detail
- HS 30042000 1 100% >
Trading Area
Total 1- Area Transactions Per Detail
- pakistan 2 100.00% >